Document Type : Research Paper I Open Access I Released under CC BY-NC 4.0 license


1 PhD Candidate Department of Exercise Physiology, Faculty of Physical Education and Sport Sciences, Guilan University, Rasht, Iran,

2 Professor, Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, Guilan University, Rasht, Iran,

3 Professor, Department of Obstetrics and Gynecology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Assistant Professor, Department of Nutritional Sciences, Endocrinology and Metabolism Research Institute, Iran University of Medical Sciences, Tehran, Iran


The aim of this study was to investigate the effect of three months of lifestyle interventions including unsupervised moderate intensity aerobic exercise and low-calorie diet on hormonal, metabolic and anthropometric parameters in overweight and obese infertile women with polycystic ovary syndrome (PCOS). The method of this study was experimental with pretest-posttest design and applied approach. Among infertile women with PCOS referred to Arash Hospital in Tehran, 20 women (age 27.9±2.5 years, weight 81.36±8.05 kg and body mass index 30.27±1.97 kg/m2) were selected as the statistical sample and randomly were divided into two experimental (n=10) and control (n=10) groups. Exercise program and diet were prescribed based on the demographic characteristics of the experimental group. Hormonal, metabolic and anthropometric parameters of the subjects were measured before and after three months.Intragroup comparison was performed with paired sample t-test and intergroup comparison with ANKOVA test in spss software (P<0.05). In the experimental group, a significant decrease in antimullerian hormone (P=0.016) and total testosterone (P=0.000) was observed. Also, weight, BMI, WC, WHR (P=0.000), systolic blood pressure (P=0.003), fasting blood glucose (P=0.019), TG (P=0.000) and LDL (P=0.035) significantly decreased and HDL (P=0.002) significantly increased. Therefore, it is recommended that this type of interventions be prescribed before or simultaneously with medical treatment for overweight and obese infertile women with PCOS.


  1. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and sterility. 2016;106(1):6-15.
  2. ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility. 2004;81(1):19-25.
  3. Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, et al. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016;207:214-9.
  4. Franks S, Berga SL. Does PCOS have developmental origins? Fertility and sterility. 2012;97(1):2-6.
  5. Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, et al. Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clinical endocrinology. 2014;81(6):899-906.
  6. Knight PG, Glister C. TGF-β superfamily members and ovarian follicle development. Reproduction. 2006;132(2):191-206.
  7. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nature reviews Disease primers. 2016;2(1):1-18.
  8. Fiçicioǧlu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertility and sterility. 2006;85(3):592-6.
  9. Dalle Grave R, Calugi S, Centis E, Marzocchi R, El Ghoch M, Marchesini G. Lifestyle modification in the management of the metabolic syndrome: achievements and challenges. Diabetes, metabolic syndrome and obesity: targets and therapy. 2010;3:373.
  10. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human reproduction. 2018;33(9):1602-18.
  11. Thomson R, Buckley J, Moran L, Noakes M, Clifton P, Norman R, et al. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human Reproduction. 2009;24(8):1976-81.
  12. Moran LJ, Harrison CL, Hutchison SK, Stepto N, Strauss BJ, Teede HJ. Exercise Decreases Anti-Müllerian Hormone in Anovulatory Overweight Women with Polycystic Ovary Syndrome–A Pilot Study. Hormone and metabolic research. 2011;43(13):977-9.
  13. Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, et al. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2012;163(2):185-9.
  14. Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial. Fertility and sterility. 2013;100(4):1096-102.
  15. Moini A, Arabipoor A, Hemat M, Ahmadi J, Salman-Yazdi R, Zolfaghari Z. The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome. Gynecological Endocrinology. 2019;35(2):119-23.
  16. Wu X, Wu H, Sun W, Wang C. Improvement of anti-Müllerian hormone and oxidative stress through regular exercise in Chinese women with polycystic ovary syndrome. Hormones. 2021;20(2):339-45.
  17. Bentlage E, Ammar A, How D, Ahmed M, Trabelsi K, Chtourou H, et al. Practical recommendations for maintaining active lifestyle during the COVID-19 pandemic: a systematic literature review. International journal of environmental research and public health. 2020;17(17):6265.
  18. Medicine ACoS. ACSM's guidelines for exercise testing and prescription: Lippincott Williams & Wilkins; 2013.
  19. Chen MJ, Fan X, Moe ST. Criterion-related validity of the Borg ratings of perceived exertion scale in healthy individuals: a meta-analysis. Journal of sports sciences. 2002;20(11):873-99.
  20. She J, Nakamura H, Makino K, Ohyama Y, Hashimoto H. Selection of suitable maximum-heart-rate formulas for use with Karvonen formula to calculate exercise intensity. International journal of automation and computing. 2015;12(1):62-9.
  21. Fawcett K, Martinez A, Crimmins M, Sims C, Børsheim E, Andres A. Effect of a dietary and exercise intervention in women with overweight and obesity undergoing fertility treatments: protocol for a randomized controlled trial. BMC nutrition. 2021;7(1):1-12.
  22. Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Jama. 2001;285(19):2486-97.
  23. Kałużna M, Człapka-Matyasik M, Wachowiak-Ochmańska K, Moczko J, Kaczmarek J, Janicki A, et al. Effect of central obesity and hyperandrogenism on selected inflammatory markers in patients with PCOS: a WHtR-matched case-control study. Journal of clinical medicine. 2020; 3024 9 (9).60.
  24. Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Systematic reviews. 2019;8(1):1-28.
  25. Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. Journal of Functional Morphology and Kinesiology. 2020;5(2):35.
  26. Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC endocrine disorders. 2020;20:1-17.
  27. Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, et al. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Human Reproduction. 2010;25(11):2783-91.
  28. Sprung VS, Cuthbertson DJ, Pugh CJ, Aziz N, Kemp GJ, Daousi C, et al. Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness. Med Sci Sports Exerc. 2013;45(12):2234-42.
  29. Kodama S, Torrealday S. Pharmacologic Treatments for PCOS Patients. Clinical obstetrics and gynecology. 2021;64(1):55-64.
  30. Awoke MA, Earnest A, Joham AE, Hodge AM, Teede HJ, Brown WJ, et al. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Human Reproduction. 2022;37(1):129-41.